Michael Garrison, PhD ()

WW President, BD Surgery, Becton Dickinson

Affiliate Associate Professor, Department of Bioengineering, University of Washington

Dr. Garrison is the WW President of the Becton Dickinson (BD) Interventional-Surgery Business Unit, responsible for developing advanced solutions for tissue reconstruction, optimized surgical process outcomes, infection risk reduction, and palliative care. Prior to his current position, Mike has held a series of roles of increasing technical and business responsibility including: WW Vice-President and General Manager, BD Infusion Solutions, Vice President of R&D, BD Medication and Procedural Solutions, Senior Business Director, BD Hypodermic and Anesthesia Systems, and Director of Advanced Technology. Prior to BD, Dr. Garrison served as Manager of R&D for the surgical heart valve franchise at Edwards Lifesciences, Global Marketing Manager at Roche Diagnostics, and as a Research Scientist at Cygnus Therapeutic Systems. Dr. Garrison received BS and MS degrees in biomedical engineering from Duke University, and a PhD in bioengineering from the University of Washington, where he was advised by Dr. Buddy Ratner. He currently and previously has served on the boards of a number of investment companies of BD. He is currently an Affiliate Associate Professor in the University of Washington Department of Bioengineering.